All-in-one inorganic nanoagents for near-infrared-II photothermal-based cancer theranostics
Source abstract
Abstract
Theranostic nanoplatforms combining various diagnostic and therapeutic units together have attracted increasing attention over the past few decades. Owing to the merits of non-invasiveness, spatiotemporal controllability, high treatment efficacy and low normal-tissue damage, photothermal therapy (PTT) especially near-infrared-II (NIR-II, 1000–1700 nm) light-triggered PTT becomes one of the most popular therapeutic modalities. Interestingly, photothermal agents (PTAs) used for PTT often have an intrinsic photoacoustic (PA) imaging function, which means that PTAs alone can serve as all-in-one theranostic nanoplatforms. With the rapid development of nanomedicine, a single photothermal agent can be endowed with desirable photothermal conversion efficiency (PCE) in the NIR-II biowindow as well as possessing diverse treatment capabilities. This review summarizes the most recent advances of inorganic PTAs for imaging-guided NIR-II PTT, PTT/photodynamic therapy (PDT), PTT/chemodynamic therapy (CDT), PTT/radiotherapy (RT), PTT/sonodynamic therapy (SDT), PTT/PDT/CDT and PTT/SDT/immunotherapy. Potential obstacles and perspectives for future research and clinical translation of such novel nanotheranostics are also discussed.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging · Extracellular vesicles in disease
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives
2. Nanoparticle-based drug delivery systems with platinum drugs for overcoming cancer drug resistance10.1039/D1TB00753J ↗
3. A C5N2 nanoparticle based direct nucleus delivery platform for synergistic cancer therapy10.1002/ange.201900884 ↗
4. Dual-stimuli-responsive, polymer-microsphere-encapsulated CuS nanoparticles for magnetic resonance imaging guided synergistic chemo-photothermal therapy10.1021/acsbiomaterials.7b00204 ↗
5. Dual-depletion of intratumoral lactate and ATP with radicals generation for cascade metabolic-chemodynamic therapy10.1002/advs.202102595 ↗
6. Iron self-boosting polymer nanoenzyme for low-temperature photothermal-enhanced ferrotherapy10.1021/acsami.1c01658 ↗
7. Combination of photothermal, prodrug and tumor cell camouflage technologies for triple-negative breast cancer treatment10.1016/j.mtadv.2021.100199 ↗
8. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer10.1039/C8CS00618K ↗
9. Organic small molecule based photothermal agents with molecular rotors for malignant breast cancer therapy10.1002/adfm.201907093 ↗
10. NIR-II-driven and glutathione depletion-enhanced hypoxia-irrelevant free radical nanogenerator for combined cancer therapy
11. Noble metal nanomaterials for NIR-triggered photothermal therapy in cancer10.1002/adhm.202001806 ↗
12. Synthesis, modification and bioapplications of nanoscale copper chalcogenides10.1039/D0TB00182A ↗
13. NIR-II responsive inorganic 2D nanomaterials for cancer photothermal therapy: recent advances and future challenges10.1002/adfm.202101625 ↗
14. Recent advances in combination of copper chalcogenide-based photothermal and reactive oxygen species-related therapies10.1021/acsbiomaterials.0c00830 ↗
15. Recent development of photothermal agents (PTAs) based on small organic molecular dyes10.1002/cbic.202000089 ↗
16. Conjugated polymer materials for photothermal therapy10.1002/adtp.201800057 ↗
17. Photothermal conjugated polymers and their biological applications in imaging and therapy10.1021/acsapm.0c00672 ↗
18. Photoacoustic imaging and photothermal therapy of semiconducting polymer nanoparticles: signal amplification and second near-infrared construction10.1002/smll.202004723 ↗
19. Liposomal indocyanine green for enhanced photothermal therapy10.1021/acsami.6b16801 ↗
20. Indocyanine green-carrying polymeric nanoparticles with acid-triggered detachable PEG coating and drug release for boosting cancer photothermal therapy10.1016/j.colsurfb.2021.112048 ↗
21. Black phosphorus nanosheet-based drug delivery system for synergistic photodynamic/photothermal/chemotherapy of cancer10.1002/adma.201603864 ↗
22. Overview of the application of inorganic nanomaterials in cancer photothermal therapy10.1039/D0BM00222D ↗
23. Light-responsive inorganic biomaterials for biomedical applications10.1002/advs.202000863 ↗
24. Recent advances in single Fe-based nanoagents for photothermal–chemodynamic cancer therapy10.3390/bios12020086 ↗
25. Inorganic nanomaterials for photothermal-based cancer theranostics10.1002/adtp.202000207 ↗
26. Through scalp and skull NIR-II photothermal therapy of deep orthotopic brain tumors with precise photoacoustic imaging guidance10.1002/adma.201802591 ↗
27. Bright aggregation-induced-emission dots for targeted synergetic NIR-II fluorescence and NIR-I photoacoustic imaging of orthotopic brain tumors10.1002/adma.201800766 ↗
28. Recent advances of polyoxometalates in multi-functional imaging and photothermal therapy10.1039/D0TB01375G ↗
29. The evolution of gadolinium based contrast agents: from single-modality to multi-modality10.1039/C6NR00267F ↗
30. Construction multifunctional nanozyme for synergistic catalytic therapy and phototherapy based on controllable performance10.1016/j.jcis.2021.11.183 ↗
31. Ultra-dispersed biomimetic nanoplatform fabricated by controlled etching agglomerated MnO2 for enhanced photodynamic therapy and immune activation10.1016/j.cej.2020.125478 ↗
32. Photoacoustic imaging: contrast agents and their biomedical applications10.1002/adma.201805875 ↗
33. Engineering plasmonic nanoparticles for enhanced photoacoustic imaging10.1021/acsnano.0c05215 ↗
34. Second near-infrared absorbing agents for photoacoustic imaging and photothermal therapy10.1002/smtd.201900553 ↗
35. Prussian Blue modified Metal Organic Frameworks for imaging guided synergetic tumor therapy with hypoxia modulation10.1016/j.jallcom.2020.157329 ↗
36. Magnetic targeted near-infrared II PA/MR imaging guided photothermal therapy to trigger cancer immunotherapy10.7150/thno.43604 ↗
37. Bimetallic nanodots for tri-modal CT/MRI/PA imaging and hypoxia-resistant thermoradiotherapy in the NIR-II biological windows10.1016/j.biomaterials.2019.119656 ↗
38. Mussel-inspired polydopamine-coated lanthanide nanoparticles for NIR-II/CT dual imaging and photothermal therapy10.1021/acsami.7b06109 ↗
39. Biocompatible small organic molecule phototheranostics for NIR-II fluorescence/photoacoustic imaging and simultaneous photodynamic/photothermal combination therapy10.1039/C9QM00036D ↗
40. All-in-one phototheranostics: single laser triggers NIR-II fluorescence/photoacoustic imaging guided photothermal/photodynamic/chemo combination therapy10.1002/adfm.201901480 ↗
41. Polymer-based therapeutic nanoagents for photothermal-enhanced combination cancer therapy10.1002/sstr.202100110 ↗
42. Two-dimensional nanomaterials for photothermal therapy10.1002/ange.201911477 ↗
43. Second near-infrared photothermal materials for combinational nanotheranostics10.1039/D0CS00664E ↗
44. NIR-II functional materials for photoacoustic theranostics10.1021/acs.bioconjchem.1c00520 ↗
45. Metallic nanoparticles as drug delivery system for the treatment of cancer, Expert Opin
46. Near-infrared inorganic nanomaterials-based nanosystem for photothermal therapy10.1039/D1NR00323B ↗
47. Facile preparation of versatile gadolinium-chelated protein nanocomposite for T1 magnetic resonance imaging-guided photodynamic and photothermal synergetic therapy10.1039/C8TB00148K ↗
48. BSA-coated gold nanorods for NIR-II photothermal therapy10.1186/s11671-021-03627-7 ↗
49. Activatable NIR-II plasmonic nanotheranostics for efficient photoacoustic imaging and photothermal cancer therapy10.1002/adma.202006532 ↗
50. Biomedical applications of liquid metal nanoparticles: a critical review10.3390/bios10120196 ↗
51. Microfluidic mass production of stabilized and stealthy liquid metal nanoparticles10.1002/smll.201800118 ↗
52. PEGylated indium nanoparticles: a metallic contrast agent for multiwavelength photoacoustic imaging and second near-infrared photothermal therapy10.1021/acsami.1c13578 ↗
53. Activating layered metal oxide nanomaterials via structural engineering as biodegradable nanoagents for photothermal cancer therapy10.1002/smll.202007486 ↗
54. Engineered exosome-mediated near-infrared-II region V2C quantum dot delivery for nucleus-target low-temperature photothermal therapy
55. Spatiotemporal dynamics of the nuclear pore complex transport barrier resolved by high-speed atomic force microscopy10.1038/nnano.2016.62 ↗
56. Nucleus-targeting ultrasmall ruthenium (iv) oxide nanoparticles for photoacoustic imaging and low-temperature photothermal therapy in the NIR-II window10.1039/C9CC09728G ↗
57. Hollow Cu2Se nanozymes for tumor photothermal-catalytic therapy10.1021/acs.chemmater.9b01958 ↗
58. Monodispersed CuSe sensitized covalent organic framework photosensitizer with an enhanced photodynamic and photothermal effect for cancer therapy10.1021/acsami.9b08394 ↗
59. Transition metal dichalcogenides for sensing and oncotherapy: status, challenges, and perspective10.1002/adfm.202004408 ↗
60. Recent developments in 2D transition metal dichalcogenides: phase transition and applications of the (quasi-) metallic phases10.1039/D1CS00236H ↗
61. Development of nickel Selenide@polydopamine nanocomposites for magnetic resonance imaging guided NIR-II photothermal therapy10.1002/adhm.202101542 ↗
62. Enhancing magnetic resonance/photoluminescence imaging-guided photodynamic therapy by multiple pathways10.1016/j.biomaterials.2019.01.044 ↗
63. Degradable and excretable ultrasmall transition metal selenide nanodots for high-performance computed tomography bioimaging-guided photonic tumor nanomedicine in NIR-II biowindow10.1002/adfm.202008591 ↗
64. Carambola-like Bi2Te3 superstructures with enhanced photoabsorption for highly efficient photothermal therapy in the second near-infrared biowindow10.1039/D1TB00694K ↗
65. Renal-clearable nickel-doped carbon dots with boosted photothermal conversion efficiency for multimodal imaging-guided cancer therapy in the second near-infrared biowindow10.1002/adfm.202100549 ↗
66. Review of functionalized nanomaterials for photothermal therapy of cancers10.1021/acsanm.1c01903 ↗
67. Nanoagent-promoted mild-temperature photothermal therapy for cancer treatment10.1002/adfm.202100738 ↗
68. Ag2S nanoparticle-mediated multiple ablations reinvigorates the immune response for enhanced cancer photo-immunotherapy10.1016/j.biomaterials.2020.120451 ↗
69. Enzyme-responsive copper sulphide nanoparticles for combined photoacoustic imaging, tumor-selective chemotherapy and photothermal therapy10.1039/c3cc40608c ↗
70. Recent advances in hyperthermia therapy-based synergistic immunotherapy10.1002/adma.202004788 ↗
71. Nanoscale metal–organic framework composites for phototherapy and synergistic therapy of cancer10.1039/D0QM00786B ↗
72. Near-infrared photoactivated nanomedicines for photothermal synergistic cancer therapy10.1016/j.nantod.2020.101073 ↗
73. Synergy of hypoxia relief and heat shock protein inhibition for phototherapy enhancement
74. Gambogic acid augments black phosphorus quantum dots (BPQDs)-based synergistic chemo-photothermal therapy through downregulating heat shock protein expression10.1016/j.cej.2020.124312 ↗
75. Exfoliation and in situ functionalization of MoS2 nanosheets for MRI-guided combined low-temperature photothermal therapy and chemotherapy10.1016/j.matdes.2021.110020 ↗
76. Hollow magnetic nanosystem-boosting synergistic effect between magnetic hyperthermia and sonodynamic therapy via modulating reactive oxygen species and heat shock proteins10.1016/j.cej.2020.124521 ↗
77. All-in-one molecular aggregation-induced emission theranostics: fluorescence image guided and mitochondria targeted chemo-and photodynamic cancer cell ablation10.1021/acs.chemmater.0c01187 ↗
78. Multifunctional oxygen-enriching nano-theranostics for cancer-specific magnetic resonance imaging and enhanced photodynamic/photothermal therapy10.1007/s12274-020-2646-7 ↗
79. Black titania-based theranostic nanoplatform for single NIR laser induced dual-modal imaging-guided PTT/PDT10.1016/j.biomaterials.2016.01.009 ↗
80. Ultrasmall MoS2 nanodots-doped biodegradable SiO2 nanoparticles for clearable FL/CT/MSOT imaging-guided PTT/PDT combination tumor therapy10.1021/acsami.8b18924 ↗
81. A full-spectrum responsive B-TiO2@SiO2–HA nanotheranostic system for NIR-II photoacoustic imaging-guided cancer phototherapy10.1039/D0TB02952A ↗
82. Black SnO2−x based nanotheranostic for imaging-guided photodynamic/photothermal synergistic therapy in the second near-infrared window10.1016/j.actbio.2021.05.041 ↗
83. Full-spectrum responsive ZrO2-based phototheranostic agent for NIR-II photoacoustic imaging-guided cancer phototherapy10.1039/D0BM01482F ↗
84. Fe3O4@Pt nanoparticles to enable combinational electrodynamic/chemodynamic therapy
85. One-pot synthesis of a self-reinforcing cascade bioreactor for combined photodynamic/chemodynamic/starvation therapy10.1016/j.jcis.2021.03.173 ↗
86. Recent advances in enhanced chemodynamic therapy strategies10.1016/j.nantod.2021.101162 ↗
87. Engineering nanomedicine for glutathione depletion-augmented cancer therapy10.1039/D0CS00718H ↗
88. Mitochondria-targeting MoS2-based nanoagents for enhanced NIR-II photothermal-chemodynamic synergistic oncotherapy10.1021/acsami.1c18311 ↗
89. Polypyrrole-based nanotheranostic agent for MRI guided photothermal-chemodynamic synergistic cancer therapy10.1039/D1NR05508A ↗
90. Synthesis of one-for-all type Cu5FeS4 nanocrystals with improved near infrared photothermal and Fenton effects for simultaneous imaging and therapy of tumor10.1016/j.jcis.2021.02.037 ↗
91. Fe-doped polyoxometalate as acid-aggregated nanoplatform for NIR-II photothermal-enhanced chemodynamic therapy10.1002/adhm.202000005 ↗
92. MSCs-engineered biomimetic PMAA nanomedicines for multiple bioimaging-guided and photothermal-enhanced radiotherapy of NSCLC
93. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy10.1016/j.biomaterials.2012.05.047 ↗
94. Nanoparticles for targeted cancer radiotherapy10.1007/s12274-020-2957-8 ↗
95. X-ray-triggered NO-released Bi–SNO nanoparticles: all-in-one nano-radiosensitizer with photothermal/gas therapy for enhanced radiotherapy10.1039/D0NR04634E ↗
96. Dual-stimuli-responsive multifunctional Gd2Hf2O7 nanoparticles for MRI-guided combined chemo-/photothermal-/radiotherapy of resistant tumors10.1021/acsami.0c09422 ↗
97. Stellate plasmonic exosomes for penetrative targeting tumor nir-ii thermo-radiotherapy10.1021/acsami.0c09969 ↗
98. Design and application of inorganic nanoparticles for sonodynamic cancer therapy10.1039/D0BM01875A ↗
99. Dual-sonosensitizer loaded phase-transition nanoparticles with tumor-targeting for synergistically enhanced sonodynamic therapy10.1039/D1BM00918D ↗
100. Liquid exfoliation of TiN nanodots as novel sonosensitizers for photothermal-enhanced sonodynamic therapy against cancer10.1016/j.nantod.2021.101170 ↗